IP Library Granted Patent US 8,012,965
Granted Patent B2
US 8,012,965 · App. 11/966,942 · Granted Sep 6, 2011

Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,012,965
App. No.
11/966,942
Granted
Sep 6, 2011
Kind
B2
Abstract

Bridged bicyclic aryl or heteroaryl substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the compounds in treating diseases or conditions associated with Axl activity are also disclosed.

Claims (93)

1. A compound of formula (Ia):

wherein:

R 1 , R 4 and R 5 are each hydrogen;

R 2 is selected from the group consisting of aryl and heteroaryl, each optionally substituted by one or more substitutents selected from the group consisting of alkyl, alkenyl, halo, haloalkyl, haloalkenyl, oxo, thioxo, cyano, nitro, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 15 —OR 14 , —R 15 —OC(O)—R 14 , —R 15 —N(R 14 ) 2 , —R 15 —C(O)R 14 , —R 15 —C(O)OR 14 , —R 15 —C(O)N(R 14 ) 2 , —R 15 —N(R 14 )C(O)OR 14 , —R 15 —N(R 14 )C(O)R 14 , —R 15 —N(R 14 )S(O) t R 14 (where t is 1 or 2), —R 15 —S(O) t OR 14 (where t is 1 or 2), —R 15 —S(O) p R 14 (where p is 0, 1 or 2), and —R 15 —S(O) t N(R 14 ) 2 (where t is 1 or 2), where each R 14 is independently hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heteroarylalkyl, and each R 15 is independently a direct bond or a straight or branched alkylene or alkenylene chain;

R 3 is a bridged bicyclic aryl or a bridged bicyclic heteroaryl of formula (II):

where:

m and n are independently 1 to 2;

q and r are independently 0 to 2;

A 1 , A 3 and each A 4 are each independently selected from the group consisting of C(R 8 ) 2 and N(R 9 );

each A 2 is independently selected from the group consisting of C(R 8 ) and N;

B 1 , B 2 , B 3 and B 4 are each independently selected from the group consisting of C(R 13 ) and N, provided that one of B 1 , B 2 , B 3 and B 4 is a carbon directly bonded to the nitrogen to which R 3 is attached;

each R 6 and R 7 is independently selected from the group consisting of hydrogen, alkyl, haloalkyl, hydroxyalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 11 —OR 9 , —R 11 —CN, —R 11 —NO 2 , —R 11 —N(R 9 ) 2 , —R 11 —C(O)OR 9 and —R 11 —C(O)N(R 9 ) 2 , or any R 6 and R 7 , together with the common nitrogen to which they are both attached, form an optionally substituted N-heteroaryl or an optionally substituted N-heterocyclyl;

each R 8 is independently selected from the group consisting of hydrogen, cyano, nitro, halo, haloalkyl, alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, —R 10 —OR 9 , —R 10 —OC(O)—R 9 , —R 10 —N(R 6 )R 7 , —R 10 —C(O)R 9 , —R 10 —C(O)OR 9 , —R 10 —C(O)N(R 6 )R 7 , —R 10 —N(R 6 )C(O)OR 14 , —R 10 —N(R 6 )C(O)R 9 , —R 10 —N(R 6 )S(O) t R 9 (where t is 1 or 2), —R 10 —S(O) t OR 9 (where t is 1 or 2), —R 10 —S(O) p R 9 (where p is 0, 1 or 2), and —R 10 —S(O) t N(R 6 )R 7 (where t is 1 or 2), or two R 8 's on adjacent carbons can combine to form a double bond;

each R 9 is independently selected from the group consisting of hydrogen, alkyl, alkenyl, haloalkyl, haloalkenyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, and optionally substituted heteroarylalkyl;

each R 10 is independently selected from the group consisting of a direct bond and an optionally substituted straight or branched alkylene chain;

each R 11 is an optionally substituted straight or branched alkylene chain;

each R 13 is independently selected from the group consisting of hydrogen, cyano, nitro, halo, haloalkyl, alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, —R 10 —OR 9 , —R 10 —OC(O)—R 9 , —R 10 —N(R 6 )R 7 , —R 10 —C(O)R 9 , —R 10 —C(O)OR 9 , —R 10 —C(O)N(R 6 )R 7 , —R 10 —N(R 6 )C(O)OR 14 , —R 10 —N(R 6 )C(O)R 9 , —R 10 —N(R 6 )S(O) t R 9 (where t is 1 or 2), —R 10 —S(O) t OR 9 (where t is 1 or 2), —R 10 —S(O) p R 9 (where p is 0, 1 or 2), and —R 10 —S(O) t N(R 6 )R 7 (where t is 1 or 2).

2. The compound of claim 1 wherein:

R 1 , R 4 and R 5 are each hydrogen;

R 2 is selected from the group consisting of a monocyclic aryl and a monocyclic heteroaryl, each optionally substituted by one or more substitutents selected from the group consisting of alkyl, alkenyl, halo, haloalkyl, haloalkenyl, oxo, thioxo, cyano, nitro, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 15 —OR 14 , —R 15 —OC(O)—R 14 , —R 15 —N(R 14 ) 2 , —R 15 —C(O)R 14 , —R 15 —C(O)OR 14 , —R 15 —C(O)N(R 14 ) 2 , —R 15 —N(R 14 )C(O)OR 14 , —R 15 —N(R 14 )C(O)R 14 , —R 15 —N(R 14 )S(O) t R 14 (where t is 1 or 2), —R 15 —S(O) t OR 14 (where t is 1 or 2), —R 15 —S(O) p R 14 (where p is 0, 1 or 2), and —R 15 —S(O) t N(R 14 ) 2 (where t is 1 or 2), where each R 14 is independently hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heteroarylalkyl, and each R 15 is independently a direct bond or a straight or branched alkylene or alkenylene chain;

R 3 is a bridged bicyclic aryl or a bridged bicyclic heteroaryl of formula (II):

where:

m and n are independently 1 to 2;

q and r are independently 0 to 2;

A 1 , A 3 and each A 4 are each independently selected from the group consisting of C(R 8 ) 2 and N(R 9 );

each A 2 is independently selected from the group consisting of C(R 8 ) and N;

B 1 , B 2 , B 3 and B 4 are each independently selected from the group consisting of C(R 13 ) and N, provided that one of B 1 , B 2 , B 3 and B 4 is a carbon directly bonded to the nitrogen to which R 3 is attached;

each R 6 and R 7 is independently selected from the group consisting of hydrogen, alkyl, haloalkyl, hydroxyalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 11 —OR 9 , —R 11 —CN, —R 11 —NO 2 , —R 11 —N(R 9 ) 2 , —R 11 —C(O)OR 9 and —R 11 —C(O)N(R 9 ) 2 , or any R 6 and R 7 , together with the common nitrogen to which they are both attached, form an optionally substituted N-heteroaryl or an optionally substituted N-heterocyclyl;

each R 8 is independently selected from the group consisting of hydrogen, cyano, nitro, halo, haloalkyl, alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, —R 10 —OR 9 , —R 10 —OC(O)—R 9 , —R 10 —N(R 6 )R 7 , —R 10 —C(O)R 9 , —R 10 —C(O)OR 9 , —R 10 —C(O)N(R 6 )R 7 , —R 10 —N(R 6 )C(O)OR 14 , —R 10 —N(R 6 )C(O)R 9 , —R 10 —N(R 6 )S(O) t R 9 (where t is 1 or 2), —R 10 —S(O) t OR 9 (where t is 1 or 2), —R 10 —S(O) p R 9 (where p is 0, 1 or 2), and —R 10 —S(O) t N(R 6 )R 7 (where t is 1 or 2), or two R 8 's on adjacent carbons can combine to form a double bond;

each R 9 is independently selected from the group consisting of hydrogen, alkyl, alkenyl, haloalkyl, haloalkenyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, and optionally substituted heteroarylalkyl;

each R 10 is independently selected from the group consisting of a direct bond and an optionally substituted straight or branched alkylene chain;

each R 11 is an optionally substituted straight or branched alkylene chain;

each R 13 is independently selected from the group consisting of hydrogen, cyano, nitro, halo, haloalkyl, alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, —R 10 —OR 9 , —R 10 —OC(O)—R 9 , —R 10 —N(R 6 )R 7 , —R 10 —C(O)R 9 , —R 10 —C(O)OR 9 , —R 10 —C(O)N(R 6 )R 7 , —R 10 —N(R 6 )C(O)OR 14 , —R 10 —N(R 6 )C(O)R 9 , —R 10 —N(R 6 )S(O) t R 9 (where t is 1 or 2), —R 10 —S(O) t OR 9 (where t is 1 or 2), —R 10 —S(O) p R 9 (where p is 0, 1 or 2), and —R 10 —S(O) t N(R 6 )R 7 (where t is 1 or 2).

3. The compound of claim 2 wherein:

R 1 , R 4 and R 5 are each hydrogen;

R 2 is selected from the group consisting of a monocyclic aryl and a monocyclic heteroaryl, each optionally substituted by one or more substitutents selected from the group consisting of alkyl, alkenyl, halo, haloalkyl, haloalkenyl, cyano, nitro, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 15 —OR 14 , —R 15 —OC(O)—R 14 , —R 15 —N(R 14 ) 2 , —R 15 —C(O)R 14 , —R 15 —C(O)OR 14 , —R 15 —C(O)N(R 14 ) 2 , —R 15 —N(R 14 )C(O)OR 14 , —R 15 —N(R 14 )C(O)R 14 , —R 15 —N(R 14 )S(O) t R 14 (where t is 1 or 2), —R 15 —S(O) t OR 14 (where t is 1 or 2), —R 15 —S(O) p R 14 (where p is 0, 1 or 2), and —R 15 —S(O) t N(R 14 ) 2 (where t is 1 or 2), where each R 14 is independently hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heteroarylalkyl, and each R 15 is independently a direct bond or a straight or branched alkylene or alkenylene chain;

R 3 is a bridged bicyclic heteroaryl of formula (II):

where:

m and n are independently 1 to 2;

q and r are independently 0 to 2;

A 1 , A 3 and each A 4 are each independently selected from the group consisting of C(R 8 ) 2 and N(R 9 );

each A 2 is independently selected from the group consisting of C(R 8 ) and N;

B 1 , B 2 , B 3 and B 4 are each independently selected from the group consisting of C(R 13 ) and N, provided that at least one of B 1 , B 2 , B 3 and B 4 is N and provided that one of B 1 , B 2 , B 3 and B 4 is a carbon directly bonded to the nitrogen to which R 3 is attached;

each R 6 and R 7 is independently selected from the group consisting of hydrogen, alkyl, haloalkyl, hydroxyalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 11 —OR 9 , —R 11 —CN, —R 11 —NO 2 , —R 11 —N(R 9 ) 2 , —R 11 —C(O)OR 9 and —R 11 —C(O)N(R 9 ) 2 , or any R 6 and R 7 , together with the common nitrogen to which they are both attached, form an optionally substituted N-heteroaryl or an optionally substituted N-heterocyclyl;

each R 8 is independently selected from the group consisting of hydrogen, cyano, nitro, halo, haloalkyl, alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, —R 10 —OR 9 , —R 10 —OC(O)—R 9 , —R 10 —N(R 6 )R 7 , —R 10 —C(O)R 9 , —R 10 —C(O)OR 9 , —R 10 —C(O)N(R 6 )R 7 , —R 10 —N(R 6 )C(O)OR 14 , —R 10 —N(R 6 )C(O)R 9 , —R 10 —N(R 6 )S(O) t R 9 (where t is 1 or 2), —R 10 —S(O) t OR 9 (where t is 1 or 2), —R 10 —S(O) p R 9 (where p is 0, 1 or 2), and —R 10 —S(O) t N(R 6 )R 7 (where t is 1 or 2), or two R 8 's on adjacent carbons can combine to form a double bond;

each R 9 is independently selected from the group consisting of hydrogen, alkyl, alkenyl, haloalkyl, haloalkenyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, and optionally substituted heteroarylalkyl;

each R 10 is independently selected from the group consisting of a direct bond and an optionally substituted straight or branched alkylene chain;

each R 11 is an optionally substituted straight or branched alkylene chain;

each R 13 is independently selected from the group consisting of hydrogen, cyano, nitro, halo, haloalkyl, alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, —R 10 —OR 9 , —R 10 —OC(O)—R 9 , —R 10 —N(R 6 )R 7 , —R 10 —C(O)R 9 , —R 10 —C(O)OR 9 , —R 10 —C(O)N(R 6 )R 7 , —R 10 —N(R 6 )C(O)OR 14 , —R 10 —N(R 6 )C(O)R 9 , —R 10 —N(R 6 )S(O) t R 9 (where t is 1 or 2), —R 10 —S(O) t OR 9 (where t is 1 or 2), —R 10 —S(O) p R 9 (where p is 0, 1 or 2), and —R 10 —S(O) t N(R 6 )R 7 (where t is 1 or 2).

4. The compound of claim 3 wherein:

R 1 , R 4 and R 5 are each hydrogen;

R 2 is phenyl optionally substituted by one or more substitutents selected from the group consisting of alkyl, alkenyl, halo, haloalkyl, haloalkenyl, cyano, nitro, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 15 —OR 14 , —R 15 —OC(O)—R 14 , —R 15 —N(R 14 ) 2 , —R 15 —C(O)R 14 ; —R 15 —C(O)OR 14 , —R 15 —C(O)N(R 14 ) 2 , —R 15 —N(R 14 )C(O)OR 14 , —R 15 —N(R 14 )C(O)R 14 , —R 15 —N(R 14 )S(O) t R 14 (where t is 1 or 2), —R 15 —S(O) t OR 14 (where t is 1 or 2), —R 15 —S(O) p R 14 (where p is 0, 1 or 2), and —R 15 —S(O) t N(R 14 ) 2 (where t is 1 or 2), where each R 14 is independently hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heteroarylalkyl, and each R 15 is independently a direct bond or a straight or branched alkylene or alkenylene chain;

R 3 is a bridged bicyclic heteroaryl of formula (II):

where:

m and n are independently 1 to 2;

q and r are independently 0 to 2;

A 1 , A 3 and each A 4 are each independently C(R 8 ) 2 ;

each A 2 is independently C(R 8 ); and

B 1 is N, B 2 is the carbon directly bonded to the nitrogen to which R 3 is attached, and B 3 and B 4 are both independently C(R 13 );

each R 6 and R 7 is independently selected from the group consisting of hydrogen, alkyl, haloalkyl, hydroxyalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 11 —OR 9 , —R 11 —CN, —R 11 —NO 2 , —R 11 —N(R 9 ) 2 , —R 11 —C(O)OR 9 and —R 11 —C(O)N(R 9 ) 2 ;

each R 8 is independently selected from the group consisting of hydrogen, cyano, nitro, halo, haloalkyl, alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heteroaryl, —R 10 —OR 9 , —R 10 —OC(O)—R 9 , —R 10 —N(R 6 )R 7 , —R 10 —C(O)R 9 , —R 10 —C(O)OR 9 , —R 10 —C(O)N(R 6 )R 7 , —R 10 —N(R 6 )C(O)OR 14 , —R 10 —N(R 6 )C(O)R 9 , —R 10 —N(R 6 )S(O) t R 9 (where t is 1 or 2), —R 10 —S(O) t OR 9 (where t is 1 or 2), —R 10 —S(O) p R 9 (where p is 0, 1 or 2), and —R 10 —S(O) t N(R 6 )R 7 (where t is 1 or 2), or two R 8 's on adjacent carbons can combine to form a double bond;

each R 9 is independently selected from the group consisting of hydrogen, alkyl, alkenyl, haloalkyl, haloalkenyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, and optionally substituted cycloalkylalkyl;

each R 10 is independently selected from the group consisting of a direct bond and an optionally substituted straight or branched alkylene chain;

each R 11 is an optionally substituted straight or branched alkylene chain;

each R 13 is independently selected from the group consisting of hydrogen, cyano, nitro, halo, haloalkyl, alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, —R 10 —OR 9 , —R 10 —OC(O)—R 9 , —R 10 —N(R 6 )R 7 , —R 10 —C(O)R 9 , —R 10 —C(O)OR 9 , —R 10 —C(O)N(R 6 )R 7 , —R 10 —N(R 6 )C(O)OR 14 , —R 10 —N(R 6 )C(O)R 9 , —R 10 —N(R 6 )S(O) t R 9 (where t is 1 or 2), —R 10 —S(O) t OR 9 (where t is 1 or 2), —R 10 —S(O) p R 9 (where p is 0, 1 or 2), and —R 10 —S(O) t N(R 6 )R 7 (where t is 1 or 2).

5. The compound of claim 4 selected from the group consisting of:

1-((6R,8R)-6,8-dimethylmethano-5,6,7,8-tetrahydroquinoline-2-yl)-N 3 -(3-fluoro-4-(4-(pyrrolidin-1-yl)piperidin-1-yl)phenyl)-1H-1,2,4-triazole-3,5-diamine;

1-(7,7-dimethyl-(6R,8R)6,8-methano-5,6,7,8-tetrahydroquinoline-2-yl)-N 3 -(4-(4-methylpiperazin-1-yl)phenyl)-1H-1,2,4-triazole-3,5-diamine;

1-(7,7-dimethyl-(6R,8R)6,8-methano-5,6,7,8-tetrahydroquinoline-2-yl)-N 3 -(3-fluoro-4-(4-bicyclo[2.2.1]heptan-2-yl piperazin-1-yl)phenyl)-1H-1,2,4-triazole-3,5-diamine;

1-(5,8-methano-4-phenyl-5,6,7,8-tetrahydroquinoline-2-yl)-N 3 -(3-fluoro-4-(4-(pyrrolidin-1-yl)piperidin-1-yl)phenyl)-1H-1,2,4-triazole-3,5-diamine;

1-(5,8-methano-4-phenyl-5,6,7,8-tetrahydroquinoline-2-yl)-N 3 -(3-fluoro-4-(4-cyclohexyl piperazin-1-yl)phenyl)-1H-1,2,4-triazole-3,5-diamine;

1-(5,8-methano-4-phenyl-5,6,7,8-tetrahydroquinoline-2-yl)-N 3 -(4-(4-methylpiperazin-1-yl)phenyl)-1H-1,2,4-triazole-3,5-diamine;

1-(5,8-methano-4-phenyl-5,6,7,8-tetrahydroquinoline-2-yl)-N 3 -(3-methyl-4-(4-(4-methylpiperazin-1-yl)piperidin-1yl)phenyl)-1H-1,2,4-triazole-3,5-diamine;

1-(5,8-methano-4-thiophen-2-yl-5,6,7,8-tetrahydroquinoline-2-yl)-N 3 -(3-fluoro-4-(4-(4-methylpiperazin-1-yl)piperidin-1yl)phenyl)-1H-1,2,4-triazole-3,5-diamine;

1-(5,8-methano-4-thiophen-2-yl-5,6,7,8-tetrahydroquinoline-2-yl)-N 3 -(3-fluoro-4-(4-(pyrrolidin-1-yl)piperidin-1-yl)phenyl)-1H-1,2,4-triazole-3,5-diamine; and

1-(5,8-methano-4-thiophen-2-yl-5,6,7,8-tetrahydroquinoline-2-yl)-N 3 -(3-fluoro-4-(4-dimethylaminopiperidin-1-yl)phenyl)-1H-1,2,4-triazole-3,5-diamine.

6. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a therapeutically effective amount of a compound of formula (Ia):

wherein:

R 1 , R 4 and R 5 are each hydrogen;

R 2 is selected from the group consisting of aryl and heteroaryl, each optionally substituted by one or more substitutents selected from the group consisting of alkyl, alkenyl, halo, haloalkyl, haloalkenyl, oxo, thioxo, cyano, nitro, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 15 —OR 14 , —R 15 —OC(O)—R 14 , —R 15 —N(R 14 ) 2 , —R 15 —C(O)R 14 , —R 15 —C(O)OR 14 , —R 15 —C(O)N(R 14 ) 2 , —R 15 —N(R 14 )C(O)OR 14 , —R 15 —N(R 14 )C(O)R 14 , —R 15 —N(R 14 )S(O) t R 14 (where t is 1 or 2), —R 15 —S(O) t OR 14 (where t is 1 or 2), —R 15 —S(O) p R 14 (where p is 0, 1 or 2), and —R 15 —S(O) t N(R 14 ) 2 (where t is 1 or 2), where each R 14 is independently hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heterocyclyl, heterocyclylalkyl, heteroaryl or heteroarylalkyl, and each R 15 is independently a direct bond or a straight or branched alkylene or alkenylene chain;

R 3 is a bridged bicyclic aryl or a bridged bicyclic heteroaryl of formula (II):

where:

m and n are independently 1 to 2;

q and r are independently 0 to 2;

A 1 , A 3 and each A 4 are each independently selected from the group consisting of C(R 8 ) 2 and N(R 9 );

each A 2 is independently selected from the group consisting of C(R 8 ) and N;

B 1 , B 2 , B 3 and B 4 are each independently selected from the group consisting of C(R 13 ) and N, provided that one of B 1 , B 2 , B 3 and B 4 is a carbon directly bonded to the nitrogen to which R 3 is attached;

each R 6 and R 7 is independently selected from the group consisting of hydrogen, alkyl, haloalkyl, hydroxyalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 11 —OR 9 , —R 11 —CN, —R 11—NO 2 , —R 11 —N(R 9 ) 2 , —R 11 —C(O)OR 9 and —R 11 —C(O)N(R 9 ) 2 , or any R 6 and R 7 , together with the common nitrogen to which they are both attached, form an optionally substituted N-heteroaryl or an optionally substituted N-heterocyclyl;

each R 8 is independently selected from the group consisting of hydrogen, cyano, nitro, halo, haloalkyl, alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, —R 10 —OR 9 , —R 10 —OC(O)—R 9 , —R 10 —N(R 6 )R 7 , —R 10 —C(O)R 9 , —R 10 —C(O)OR 9 , —R 10 —C(O)N(R 6 )R 7 , —R 10 —N(R 6 )C(O)OR 14 , —R 10 —N(R 6 )C(O)R 9 , —R 10 —N(R 6 )S(O) t R 9 (where t is 1 or 2), —R 10 —S(O) t OR 9 (where t is 1 or 2), —R 10 —S(O) p R 9 (where p is 0, 1 or 2), and —R 10 —S(O) t N(R 6 )R 7 (where t is 1 or 2) or two R 8 's on adjacent carbons can combine to form a double bond;

each R 9 is independently selected from the group consisting of hydrogen, alkyl, alkenyl, haloalkyl, haloalkenyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, and optionally substituted heteroarylalkyl;

each R 10 is independently selected from the group consisting of a direct bond and an optionally substituted straight or branched alkylene chain;

each R 11 is an optionally substituted straight or branched alkylene chain;

each R 13 is independently selected from the group consisting of hydrogen, cyano, nitro, halo, haloalkyl, alkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, —R 10 —OR 9 , —R 10 —OC(O)—R 9 , —R 10 —N(R 6 )R 7 , —R 10 —C(O)R 9 , —R 10 —C(O)OR 9 , —R 10 —C(O)N(R 6 )R 7 , —R 10 —N(R 6 )C(O)OR 14 , —R 10 —N(R 6 )C(O)R 9 , —R 10 —N(R 6 )S(O) t R 9 (where t is 1 or 2), —R 10 —S(O) t OR 9 (where t is 1 or 2), —R 10 —S(O) p R 9 (where p is 0, 1 or 2), and —R 10 —S(O) t N(R 6 )R 7 (where t is 1 or 2).

Assignments (3)
SECURITY INTEREST Recorded May 8, 2026
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 075576/0880 →
SECURITY INTEREST Recorded Aug 25, 2022
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061327/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2008
From: GOFF, DANE; ZHANG, JING; SINGH, RAJINDER; HOLLAND, SACHA; DING, PINGYU; YU, JIAXIN; LITVAK, JOANE
To: RIGEL PHARMACEUTICALS, INC.
Reel/Frame 021415/0876 →